ELISA kits Design & Development of Biomarkers
Preclinical studies solutions Clinical trials solutions
Artialis' biomarker and intra-articular injection of an autologous plasma-rich-platelet.
Artialis' biomarker Coll2-1 and viscosupplementation of hyaluronic acid: results from EPIKART, a Pilot Prospective Comparative Randomized Double Blind Trial.
We needed a specific measure for the cartilage degeneration to prove the efficacy of our product. The collaboration with Artialis was a logical choice